Search Results - "Nijsen, Johannes F W"

Refine Results
  1. 1
  2. 2

    The necessity of nuclear reactors for targeted radionuclide therapies by Krijger, Gerard C, Ponsard, Bernard, Harfensteller, Mark, Wolterbeek, Hubert T, Nijsen, Johannes W.F

    Published in Trends in biotechnology (Regular ed.) (01-07-2013)
    “…Highlights • Nuclear reactors remain essential for the production of radionuclides for medicine. • The main reactors used will close before 2025. • Alternative…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Liver tumors: MR imaging of radioactive holmium microspheres--phantom and rabbit study by Nijsen, Johannes F W, Seppenwoolde, Jan-Henry, Havenith, Thomas, Bos, Clemens, Bakker, Chris J G, van het Schip, Alfred D

    Published in Radiology (01-05-2004)
    “…To investigate the use of magnetic resonance (MR) imaging in the administration and biodistribution of holmium-loaded poly(L-lactic acid) microspheres…”
    Get more information
    Journal Article
  6. 6

    Radioembolization Dosimetry: The Road Ahead by Smits, Maarten L. J., Elschot, Mattijs, Sze, Daniel Y., Kao, Yung H., Nijsen, Johannes F. W., Iagaru, Andre H., de Jong, Hugo W. A. M., van den Bosch, Maurice A. A. J., Lam, Marnix G. E. H.

    “…Methods for calculating the activity to be administered during yttrium-90 radioembolization (RE) are largely based on empirical toxicity and efficacy analyses,…”
    Get full text
    Journal Article
  7. 7

    Holmium-Loaded Poly(l-lactic Acid) Microspheres:  In Vitro Degradation Study by Zielhuis, Sander W, Nijsen, Johannes F. W, Krijger, Gerard C, van het Schip, Alfred D, Hennink, Wim E

    Published in Biomacromolecules (01-07-2006)
    “…The clinical application of holmium-loaded poly(l-lactic acid) (PLLA) microspheres for the radionuclide treatment of liver malignancies requires in depth…”
    Get full text
    Journal Article
  8. 8

    Factors affecting the sensitivity and detection limits of MRI, CT, and SPECT for multimodal diagnostic and therapeutic agents by Seevinck, Peter R, Seppenwoolde, Jan-Henry, de Wit, Tim C, Nijsen, Johannes F W, Beekman, Freek J, van Het Schip, Alfred D, Bakker, Chris J G

    Published in Anti-cancer agents in medicinal chemistry (01-05-2007)
    “…Noninvasive imaging techniques like magnetic resonance imaging (MRI), computed tomography (CT) and single photon emission computed tomography (SPECT) play an…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Quantitative Monte Carlo-based holmium-166 SPECT reconstruction by Elschot, Mattijs, Smits, Maarten L. J., Nijsen, Johannes F. W., Lam, Marnix G. E. H., Zonnenberg, Bernard A., van den Bosch, Maurice A. A. J., Viergever, Max A., de Jong, Hugo W. A. M.

    Published in Medical physics (Lancaster) (01-11-2013)
    “…Purpose: Quantitative imaging of the radionuclide distribution is of increasing interest for microsphere radioembolization (RE) of liver malignancies, to aid…”
    Get full text
    Journal Article
  15. 15

    Radiation Emission from Patients Treated with Holmium-166 Radioembolization by Prince, Jip F., MD, Smits, Maarten L.J., MD, PhD, Krijger, Gerard C., PhD, Zonnenberg, Bernard A., MD, PhD, van den Bosch, Maurice A.A.J., MD, PhD, Nijsen, Johannes F.W., PhD, Lam, Marnix G.E.H., MD, PhD

    “…Abstract Purpose To assess the radiation exposure to individuals coming from patients after treatment with holmium-166 (166 Ho) microspheres. Materials and…”
    Get full text
    Journal Article
  16. 16

    Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases by Smits, Maarten L J, van den Hoven, Andor F, Rosenbaum, Charlotte E N M, Zonnenberg, Bernard A, Lam, Marnix G E H, Nijsen, Johannes F W, Koopman, Miriam, van den Bosch, Maurice A A J

    Published in PloS one (2013)
    “…To investigate clinical and laboratory toxicity in patients with unresectable liver metastases, treated with yttrium-90 radioembolization ((90)Y-RE). Patients…”
    Get full text
    Journal Article
  17. 17

    Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with 90Y-Microspheres for Unresectable Liver Metastases by Smits, Maarten L. J., van den Hoven, Andor F., Rosenbaum, Charlotte E. N. M., Zonnenberg, Bernard A., Lam, Marnix G. E. H., Nijsen, Johannes F. W., Koopman, Miriam, van den Bosch, Maurice A. A. J.

    Published in PloS one (24-07-2013)
    “…Objective To investigate clinical and laboratory toxicity in patients with unresectable liver metastases, treated with yttrium-90 radioembolization (90Y-RE)…”
    Get full text
    Journal Article
  18. 18

    Radionuclide liver cancer therapies: from concept to current clinical status by Vente, Maarten A D, Hobbelink, Monique G G, van Het Schip, Alfred D, Zonnenberg, Bernard A, Nijsen, Johannes F W

    Published in Anti-cancer agents in medicinal chemistry (01-07-2007)
    “…Primary and secondary liver cancer have longtime been characterized by an overall poor prognosis since the majority of patients are not candidates for surgical…”
    Get more information
    Journal Article
  19. 19

    Microbrachytherapy using holmium-166 acetylacetonate microspheres: A pilot study in a spontaneous cancer animal model by Bult, Wouter, Vente, Maarten A.D, Vandermeulen, Eva, Gielen, Ingrid, Seevinck, Peter R, Saunders, Jimmy, van het Schip, Alfred D, Bakker, Chris J.G, Krijger, Gerard C, Peremans, Kathelijne, Nijsen, Johannes F.W

    Published in Brachytherapy (01-03-2013)
    “…Abstract Purpose Holmium-166 acetylacetonate microspheres (166 Ho-AcAc-MS) are proposed as an intratumoral radioablation device. This article presents a pilot…”
    Get full text
    Journal Article
  20. 20

    Lanthanide-loaded liposomes for multimodality imaging and therapy by Zielhuis, Sander W, Seppenwoolde, Jan-Henry, Mateus, Vanessa A P, Bakker, Chris J G, Krijger, Gerard C, Storm, Gert, Zonnenberg, Bernard A, van het Schip, Alfred D, Koning, Gerben A, Nijsen, Johannes F W

    Published in Cancer biotherapy & radiopharmaceuticals (01-10-2006)
    “…Many advanced molecular imaging agents are currently being investigated preclinically. Especially, liposomes, have proven to be very promising carrier systems…”
    Get more information
    Journal Article